StockData
COSCIENS Biopharma Inc. logo

COSCIENS Biopharma Inc. (CSCIF) stock

CSCIFOTCPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 20-F on Mar 25, 2026Score 1/30
$6.49+0.00 (0.00%)

Close on Oct 19, 2026Market cap $24.10MP/E –Yield –

COSCIENS Biopharma operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

COSCIENS Biopharma's operating cash flow for the twelve months ending Mar 31, 2026 was -$8.77M. For fiscal 2025 it was -$8.47M. The highest annual figure on record is $6.83M in fiscal 2018.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$8.47M–
FY2024Dec 31, 2024-$14.57M–
FY2023Dec 31, 2023-$2.58M-149.4%
FY2022Dec 31, 2022$5.23M–
FY2021Dec 31, 2021-$8.58M–
FY2020Dec 31, 2020-$4.13M–
FY2019Dec 31, 2019-$10.73M-257.1%
FY2018Dec 31, 2018$6.83M–
FY2017Dec 31, 2017-$22.91M–
FY2016Dec 31, 2016-$29.01M–
FY2015Dec 31, 2015-$33.84M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2026Mar 31, 2026-$2.18M–
Q4 FY2025Dec 31, 2025-$1.47M–
Q3 FY2025Sep 30, 2025-$676.00K–
Q2 FY2025Jun 30, 2025-$4.45M–
Q1 FY2025Mar 31, 2025-$1.88M–
Q4 FY2024Dec 31, 2024-$3.00M–
Q3 FY2024Sep 30, 2024-$7.78M-5502.1%
Q2 FY2024Jun 30, 2024-$1.39M–
Q1 FY2024Mar 31, 2024-$2.38M–
Q4 FY2023Dec 31, 2023-$1.09M-107.0%
Q3 FY2023Sep 30, 2023$144.00K–
Q2 FY2023Jun 30, 2023-$813.00K–
Q1 FY2023Mar 31, 2023-$4.06M–
Q4 FY2022Dec 31, 2022$15.49M–
Q3 FY2022Sep 30, 2022-$3.95M–
Q2 FY2022Jun 30, 2022-$4.85M–
Q1 FY2022Mar 31, 2022-$1.46M–
Q4 FY2021Dec 31, 2021-$2.41M-195.8%
Q3 FY2021Sep 30, 2021-$1.49M–
Q2 FY2021Jun 30, 2021-$3.64M–
Q1 FY2021Mar 31, 2021-$1.05M–
Q4 FY2020Dec 31, 2020$2.52M–
Q3 FY2020Sep 30, 2020-$1.79M–
Q2 FY2020Jun 30, 2020-$2.41M–
Q1 FY2020Mar 31, 2020-$2.44M–
Q4 FY2019Dec 31, 2019-$2.95M–
Q3 FY2019Sep 30, 2019-$2.60M–
Q2 FY2019Jun 30, 2019-$2.17M–
Q1 FY2019Mar 31, 2019-$3.01M–
Q4 FY2018Dec 31, 2018-$2.68M–
Q3 FY2018Sep 30, 2018-$2.44M–
Q2 FY2018Jun 30, 2018-$4.78M–

More COSCIENS Biopharma figures

See a number that looks wrong?